-
Cost-Effectiveness Analysis of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab for Patients With High-Risk Early Stage Triple-Negative Breast Cancer in Chile
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Introducing Nirsevimab Into the National Immunization Program for Infants in Korea
Sep 9, 2025, 16:22 PM -
Unmet Needs in Late-Line Metastatic Colorectal Cancer in Portugal: An Expert-Informed Epidemiological Forecast
Sep 9, 2025, 16:22 PM -
Prediction of Query Outcomes in the Setting of Observational Studies
Sep 9, 2025, 16:22 PM -
Indirect Costs Associated With Pneumococcal Disease: A Global Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Small Molecules vs. Biologics Patterns of Indication Expansion and the Potential Impact of Medicare Price Negotiation
Sep 9, 2025, 16:22 PM -
Real-World Evidence of Atezolizumab in Unresectable Recurrent NSCLC: Insights From Japan's Next-Generation Medical Infrastructure Act
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of High-Energy High-Protein (HEHP) Oral Nutritional Support (ONS) for the Treatment of Disease-Related Malnutrition (DRM) in Cancer Patients in the French Community Setting
Sep 9, 2025, 16:22 PM -
Trends in Epidemiology and Mortality of Patients With Bladder Cancer in Germany: A Retrospective Study Using German Claims Data
Sep 9, 2025, 16:22 PM -
Identification of Clusters of Patients With Similar Baseline Characteristics in the FOCAL-MS2 Study Evaluating Patient’s Autonomy
Sep 9, 2025, 16:22 PM -
An Adjusted Indirect Comparison of Once-Weekly Insulin Efsitora Alfa vs. Insulin Icodec for Adults With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
Sep 9, 2025, 16:22 PM -
Germany: Still a Benchmark for ATMP Access and Pricing: A Pricing Analysis of Germany's ATMP Landscape Compared to Other European Countries
Sep 9, 2025, 16:22 PM -
Comparison of Clinical Outcome Assessment in Randomized Controlled Trials and in Observational Studies for Amyotrophic Lateral Sclerosis: A Scoping Review
Sep 9, 2025, 16:22 PM -
A Layered Approach to Reducing Hallucinations in LLMs for Structured and Unstructured Clinical Data
Sep 9, 2025, 16:22 PM -
Maximizing Profits Through Pricing: Opportunities in Portugal's Pharma Sector
Sep 9, 2025, 16:22 PM -
An Economic Evaluation of Risankizumab vs. Adalimumab in Moderate to Severe Plaque Psoriasis Adult Patients in Egypt
Sep 9, 2025, 16:22 PM -
The Impact of Early Antibacterial Therapy on ICU Patient Outcomes for Sepsis: A Causal Analysis
Sep 9, 2025, 16:22 PM -
An Analysis of Possible Reference Countries for a US Most-Favored Nation Policy and the Associated Impact on the Global Pharmaceutical Industry
Sep 9, 2025, 16:22 PM -
The Health Impact of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab Treatment for High-Risk Early Stage Triple-Negative Breast Cancer (eTNBC) in Türkiye
Sep 9, 2025, 16:22 PM -
Economic Burden and Healthcare Resource Utilization of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Germany: A Claims Data Analysis
Sep 9, 2025, 16:22 PM
